As the body of research expands on the potential of glucagon-like peptide-1 receptor agonists to address various health ...
A recent study found that over a third of websites selling compounded diabetes and weight loss medications, such as Ozempic and Wegovy, falsely claim they are FDA-approved.
The case for GLP-1 drugs like Ozempic possibly causing blindness is building. A new paper out this week describes several ...
Beyond treating diabetes and helping people lose weight, GLP-1s may also improve libido. But the reasons are as complex as ...
Previous studies have found that SGLT2 inhibitors appear to lower HbA1c less in patients with worse kidney function.” “GLP-1 agonists appear to be less affected by this interaction,” he added.
GLP-1 is a hormone made naturally in the gut. It plays a big role in managing blood sugar and appetite while releasing ...
A human-derived, ultra-long-acting GLP-1 injection independently researched and developed by Innogen, a Shanghai-based ...
Aadvark, which will list on the Nasdaq under the ticker “AARD” Feb. 13, will have the opportunity to bring in roughly $14.1 ...
Company reported positive Phase 2b QUALITY study topline results for enobosarm + semaglutide (Wegovy®) with study meeting prespecified primary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback